Lymphoma Clinical Trials in Uniondale, New York
20 recruitingUniondale, New York
Showing 1–20 of 20 trials
Recruiting
Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Waldenstrom MacroglobulinemiaLymphoplasmacytic Lymphoma
National Cancer Institute (NCI)92 enrolled125 locationsNCT04840602
Recruiting
Phase 3
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
National Cancer Institute (NCI)247 enrolled627 locationsNCT04269902
Recruiting
Phase 2
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
Nodular Lymphocyte Predominant B-Cell LymphomaRecurrent Nodular Lymphocyte Predominant B-Cell LymphomaRefractory Nodular Lymphocyte Predominant B-Cell Lymphoma
National Cancer Institute (NCI)70 enrolled35 locationsNCT05886036
Recruiting
Phase 1
A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)
Secondary Central Nervous System LymphomaPrimary Central Nervous System (CNS) Lymphoma
Memorial Sloan Kettering Cancer Center12 enrolled7 locationsNCT07137494
Recruiting
Phase 2
A Study of Epcoritamab With Lenalidomide and Tafasitamab in People With Diffuse Large B Cell Lymphoma
Lymphoma
Memorial Sloan Kettering Cancer Center27 enrolled7 locationsNCT07030699
Recruiting
Phase 2
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
LymphomaT-cell LeukemiaT-Cell Leukemia/Lymphoma, Adult+1 more
Memorial Sloan Kettering Cancer Center134 enrolled7 locationsNCT06698003
Recruiting
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Breast CancerLymphomaHodgkin's Lymphoma
Memorial Sloan Kettering Cancer Center475 enrolled7 locationsNCT01788839
Recruiting
Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
Lymphoma
Memorial Sloan Kettering Cancer Center83 enrolled10 locationsNCT02974647
Recruiting
Phase 1
A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)
Primary Central Nervous System LymphomaCentral Nervous System LymphomaSecondary Central Nervous System Lymphoma+4 more
Memorial Sloan Kettering Cancer Center26 enrolled8 locationsNCT07082868
Recruiting
Phase 3
A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
Follicular LymphomaMarginal Zone Lymphoma
Memorial Sloan Kettering Cancer Center375 enrolled7 locationsNCT07029217
Recruiting
Phase 2
A Study of Enasidenib in People With T-Cell Lymphoma
T-cell Lymphoma
Memorial Sloan Kettering Cancer Center25 enrolled8 locationsNCT06756308
Recruiting
Phase 1
A Study of Ruxolitinib and Duvelisib in People With Lymphoma
T-cell Prolymphocytic LeukemiaT-cell LymphomasNK-Cell Lymphomas+1 more
Memorial Sloan Kettering Cancer Center70 enrolled9 locationsNCT05010005
Recruiting
Phase 2
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
Hodgkin LymphomaRelapsed or Refractory Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center257 enrolled8 locationsNCT03618550
Recruiting
Phase 2
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
Waldenstrom MacroglobulinemiaLymphoplasmacytic Lymphoma
Memorial Sloan Kettering Cancer Center40 enrolled8 locationsNCT07231952
Recruiting
Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
Mycosis FungoidesLymphomatoid PapulosisSezary Syndrome
Memorial Sloan Kettering Cancer Center58 enrolled8 locationsNCT03587844
Recruiting
Phase 1
Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma
Follicular Lymphoma
Memorial Sloan Kettering Cancer Center100 enrolled7 locationsNCT04468841
Recruiting
Phase 1
A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
Anaplastic Large Cell LymphomaAnaplastic Lymphoma Kinase
Memorial Sloan Kettering Cancer Center30 enrolled7 locationsNCT07001384
Recruiting
Not Applicable
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
LymphomaLeukemiaMyeloma+1 more
Memorial Sloan Kettering Cancer Center60 enrolled7 locationsNCT07052916
Recruiting
A Registry for People With T-cell Lymphoma
T-cell LymphomaNK-Cell LymphomaT-cell Prolymphocytic Leukemia+27 more
Memorial Sloan Kettering Cancer Center1,000 enrolled26 locationsNCT05978141
Recruiting
Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center71 enrolled8 locationsNCT06377566